Kevin M. Picardat

Array ( [id] => 1350780 [patent_doc_number] => 06576249 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Bone putty and method' [patent_app_type] => B1 [patent_app_number] => 09/711716 [patent_app_country] => US [patent_app_date] => 2000-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3028 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576249.pdf [firstpage_image] =>[orig_patent_app_number] => 09711716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 783003 [patent_doc_number] => 06992172 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-31 [patent_title] => 'Recombinant gelatins' [patent_app_type] => utility [patent_app_number] => 09/710239 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 31 [patent_no_of_words] => 35917 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/992/06992172.pdf [firstpage_image] =>[orig_patent_app_number] => 09710239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710415 [patent_doc_number] => 07056722 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-06 [patent_title] => 'Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby' [patent_app_type] => utility [patent_app_number] => 09/709237 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3780 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056722.pdf [firstpage_image] =>[orig_patent_app_number] => 09709237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1319039 [patent_doc_number] => 06605591 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Treatment of subnormal bone mineral density' [patent_app_type] => B1 [patent_app_number] => 09/710729 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7874 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605591.pdf [firstpage_image] =>[orig_patent_app_number] => 09710729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1453817 [patent_doc_number] => 06462021 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Use of low molecular weight thrombin inhibitor' [patent_app_type] => B1 [patent_app_number] => 09/705912 [patent_app_country] => US [patent_app_date] => 2000-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4157 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462021.pdf [firstpage_image] =>[orig_patent_app_number] => 09705912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239716 [patent_doc_number] => 07592433 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-22 [patent_title] => 'Polynucleotides encoding cyclotide-like structures' [patent_app_type] => utility [patent_app_number] => 10/129201 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 24 [patent_no_of_words] => 17160 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592433.pdf [firstpage_image] =>[orig_patent_app_number] => 10129201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1544008 [patent_doc_number] => 06444209 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Hybrid botulinal neurotoxins' [patent_app_type] => B1 [patent_app_number] => 09/706047 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 10011 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444209.pdf [firstpage_image] =>[orig_patent_app_number] => 09706047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1576817 [patent_doc_number] => 06447785 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Method for treating hypercalcemia' [patent_app_type] => B1 [patent_app_number] => 09/706174 [patent_app_country] => US [patent_app_date] => 2000-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12848 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/447/06447785.pdf [firstpage_image] =>[orig_patent_app_number] => 09706174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1398251 [patent_doc_number] => 06531446 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Peptides having biological activity' [patent_app_type] => B1 [patent_app_number] => 09/600710 [patent_app_country] => US [patent_app_date] => 2000-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3435 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531446.pdf [firstpage_image] =>[orig_patent_app_number] => 09600710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602956 [patent_doc_number] => 06433135 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'PEG-LHRH analog conjugates' [patent_app_type] => B1 [patent_app_number] => 09/698134 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3765 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/433/06433135.pdf [firstpage_image] =>[orig_patent_app_number] => 09698134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1546400 [patent_doc_number] => 06444791 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Methods and compositions for the treatment of keratoconus using protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/695774 [patent_app_country] => US [patent_app_date] => 2000-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24490 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444791.pdf [firstpage_image] =>[orig_patent_app_number] => 09695774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1382713 [patent_doc_number] => 06555650 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-29 [patent_title] => 'Cyclic analogs of histatins' [patent_app_type] => B1 [patent_app_number] => 09/693822 [patent_app_country] => US [patent_app_date] => 2000-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5268 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 249 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555650.pdf [firstpage_image] =>[orig_patent_app_number] => 09693822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342361 [patent_doc_number] => 06586399 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Methods of enhancing functioning of the large intestine' [patent_app_type] => B1 [patent_app_number] => 09/692238 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8248 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586399.pdf [firstpage_image] =>[orig_patent_app_number] => 09692238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1105645 [patent_doc_number] => 06812333 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-02 [patent_title] => 'Identification of arsacs mutations and methods of use therefor' [patent_app_type] => B1 [patent_app_number] => 09/693205 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 53574 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/812/06812333.pdf [firstpage_image] =>[orig_patent_app_number] => 09693205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1304906 [patent_doc_number] => 06620967 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Ketosis-treating agent' [patent_app_type] => B1 [patent_app_number] => 09/690016 [patent_app_country] => US [patent_app_date] => 2000-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 2307 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620967.pdf [firstpage_image] =>[orig_patent_app_number] => 09690016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250555 [patent_doc_number] => 07582311 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-01 [patent_title] => 'Injection vehicle for polymer-based formulations' [patent_app_type] => utility [patent_app_number] => 09/687951 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7609 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582311.pdf [firstpage_image] =>[orig_patent_app_number] => 09687951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 663624 [patent_doc_number] => 07101969 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-05 [patent_title] => 'Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein' [patent_app_type] => utility [patent_app_number] => 09/689952 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 48 [patent_no_of_words] => 27838 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101969.pdf [firstpage_image] =>[orig_patent_app_number] => 09689952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1368991 [patent_doc_number] => 06566338 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death' [patent_app_type] => B1 [patent_app_number] => 09/685689 [patent_app_country] => US [patent_app_date] => 2000-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 10974 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566338.pdf [firstpage_image] =>[orig_patent_app_number] => 09685689 [rel_patent_id] =>[rel_patent_doc_number] =>)